	Letter to the editor regarding 'Real-world venetoclax dosing patterns and treatment persistence in patients with acute myeloid leukemia: a community pharmacy database study in Japan'. Leuk Lymphoma Borrás-Blasco J, Valcuende-Rosique A, Cornejo-Uixeda S. PMID: 42747324 [PubMed - as supplied by publisher]
	Real-World Determinants of Treatment Selection in Frontline Chronic Lymphocytic Leukemia: The FIRST-CLL Study. Hematol Oncol Perutelli F, Arata M, Pasquale R, Pepe S, Nicolosi M, Deodato M, Piras I, Fioribello E, Bosi A, Moia R, Ferrario A, Schirru M, Boccellato E, Bullo M, Gottardi D, Foglietta M, Galitzia A, Coscia M, Gaidano G, Merli M, Salvetti C, Murru R, Frustaci AM, Freilone R, Olivieri J, Mauro FR, Bruno B, Vitale C. PMID: 42747083 [PubMed - indexed for MEDLINE]
	Efficacy and safety of chimeric antigen receptor T-cell therapy in primary central nervous system lymphoma: a systematic review and meta-analysis. Immunotherapy Al-Mashdali AF, Abdelraof MO, Kaddoura R, Halfawi AM, Yousif MEM, Abdulgayoom M, Shah AR, Mohamed SF. PMID: 42746886 [PubMed - as supplied by publisher]
	Targeting lipid metabolic vulnerabilities with small-molecule inhibitors in acute myeloid leukemia: Emerging insights and therapeutic opportunities. Tzu Chi Med J Yen JH, Phan TQ, Liou JW, Chen PY. PMID: 42746650 [PubMed]
	Case Report: Blastic plasmacytoid dendritic cell neoplasm mimicking systemic lymphoma: a multidisciplinary diagnostic challenge. Front Med (Lausanne) Lv B, Rong Q, Li Y, Zhang D. PMID: 42745818 [PubMed]
	Predictors and outcomes of recurrent bloodstream infection in hematological malignancies: a multicenter real-world study. Front Cell Infect Microbiol Tang Y, Yan Y, Zhao K, Cheng Q, Wang L, Xiao Y, Fang Z, Wei Y, Li X. PMID: 42745743 [PubMed - indexed for MEDLINE]
	Plain language summary of the ZUMA-5 study of axicabtagene ciloleucel for people with relapsed or refractory slow-growing non-Hodgkin lymphoma. Future Oncol Neelapu SS, Nikolajeva O, Jacobson CA. PMID: 42745632 [PubMed - as supplied by publisher]
	Real-World Management of Chronic Myelogenous Leukemia in an Underserved Patient Cohort at a Los Angeles Safety-Net Health System: Tyrosine Kinase Inhibitor Treatment Patterns and Outcomes From 2015 to 2024. Cancer Med Zheng D, Nold T, Ramakrishnan N, Kim K, Tomassetti S. PMID: 42745440 [PubMed - indexed for MEDLINE]
	Experiences and coping strategies of time toxicity in young and middle-aged patients with lymphoma: a descriptive qualitative study. Support Care Cancer Li D, Zheng K, Chen L, Zhang M. PMID: 42744956 [PubMed - indexed for MEDLINE]
	Measurable residual disease detected by next-generation sequencing in T-cell acute lymphoblastic leukemia. Nat Commun Liao C, Chen H, Xu L, Lin S, Zhang J, Xu W, Liang J, Zhao F, Shen D, Shen H, Song H, Tang Y, Xu X. PMID: 42744807 [PubMed - indexed for MEDLINE]
	Primary central nervous system lymphoma involving the hypothalamic-pituitary axis presenting with hypopituitarism: A case report with long-term follow-up. Endocrinol Diabetes Nutr (Engl Ed) Sanchis-Pascual D, Cámara Gómez R, Morillas-Amat P, Romero Domínguez S, Carreres-Polo J, Lara-Gálvez D, Cano-Jiménez L, Díaz Nohales J, Merino-Torres JF. PMID: 42744529 [PubMed - indexed for MEDLINE]
	Occupational exposure to radiofrequency electromagnetic fields and risk of follicular lymphoma: Family case-control study. Cancer Epidemiol Mate R, Benke G, Loughran SP, Abramson MJ, Vajdic CM, Turner MC, Turuban M, Cardis E, Van Leeuwen MT, Odutola M, Hertzberg M, Bruinsma F, Seymour JF, Prince HM, Roncolato F, Opat S, Milliken S, Verner E, Lindeman R, Karipidis K. PMID: 42743897 [PubMed - as supplied by publisher]
	Treatment of acute myeloid leukemia with inv(3) or t(3;3): A single-center retrospective cohort study and literature review. Leuk Res Resto-Santos DM, Perissinotti AJ, Bixby DL, Burke PW, Pettit KM, Marini BL. PMID: 42743820 [PubMed - as supplied by publisher]
	High-risk features in adult patients with B-cell acute lymphoblastic leukemia: redefining risk in the era of targeted immunotherapy. Blood Res Baek DW. PMID: 42742788 [PubMed]
	Efficacy and safety of rituximab in the treatment of primary central nervous system lymphoma: A meta-analysis and systematic review of 1,388 patients. Oncol Lett Sun L, Li W, Chen W, Li C, Ren Z, Xie Q, Wang D. PMID: 42741313 [PubMed]
	Clinical implementation of intensity modulated proton therapy in breath-hold for mediastinal lymphoma patients using surface monitoring and nasal high-flow therapy. Phys Imaging Radiat Oncol Vilches-Freixas G, van der Klugt K, Canters R, Kneepkens E, Vereijken F, Cobben M, van den Bosch M, Lubken I, van Engelen A, Stultiens C, Velders M, Cartechini G, Unipan M, Berbée M, Ta B. PMID: 42740833 [PubMed]
	Timing matters: Impact of covalent BTK inhibitor dose modifications on outcomes in chronic lymphocytic leukemia/small lymphocytic leukemia-A 7-year real-world study. Cancer Zhang J, Luo J, Shen X, Ren J, Liu W, Chen L, Jiang L, Weng X, Wang J, Mi JQ. PMID: 42740716 [PubMed - indexed for MEDLINE]
	Correction: Venetoclax plus Modified-Intensity Idarubicin and Cytarabine Treatment as First-Line Treatment for Newly Diagnosed Pediatric Acute Myeloid Leukemia. Clin Cancer Res Wang S, Jiang M, Wang Y, Chang L, Zhao B, Liu X, Qi B, Wang S, Liu T, Zhang X, Chen Y, Liu F, Guo Y, Chen X, Zhang L, Zou Y, Yang W, Gao J, Zhu X, Ruan M. PMID: 42740585 [PubMed - in process]
	Hairy Cell Leukemia: 2026 Update on Diagnosis, Risk-Stratification, and Treatment. Am J Hematol Troussard X, Maître E, Paillassa J. PMID: 42740575 [PubMed - as supplied by publisher]
	T-lymphoblastic leukemia/lymphoma: a comprehensive review of pathology, molecular features, and differential diagnosis. J Pathol Transl Med Danielson D, Lagerstrom IT, Rogers M, Simon K, Aguilera NS, Auerbach A. PMID: 42740338 [PubMed]

Articles 1 - 20 / 170297

Page 1 of 8515



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy